Drug class of 2015 heavy on blockbusters; Isis touts more early data;

@FierceBiotech: In a squeaker, FierceBiotech readers warn of a biotech bubble. Editor's corner | Follow @FierceBiotech

@JohnCFierce: Is it important that Biogen dropped Idec? No. Will everyone comment on it? Yes. News is funny that way. More | Follow @JohnCFierce

@DamianFierce: Auxogyn is a really good name for an IVF company, imo. FierceMedicalDevices story | Follow @DamianFierce

> 2015 is shaping up to be a year full of blockbuster drug launches, Reuters says. Story

> Regeneron ($REGN) is trimming the benefits of its two top executives, axing, among other amenities, CEO Len Schleifer's $18,500 golf course membership in an effort to simplify its compensation structure. More

> Isis ($ISIS) touted more positive results for an early-stage antisense drug, ISIS-ANGPTL3 for high triglycerides, but didn't disclose how the drug performed against placebo. Item

Medical Device News

@FierceMedDev: ICYMI: Sebacia reveals positive data for acne-fighting gold microparticle device. Article | Follow @FierceMedDev

@VarunSaxena2: DOJ cracks down on devicemakers in 2014 with $100M+ in fines. Editor's corner | Follow @VarunSaxena2

@EmilyWFierce: Highlight of my Monday: Foundation Medicine's new president and COO is named Kafka. Release | Follow @EmilyWFierce

> Edwards-backed CardioKinetix reports China heart failure data, US pivotal results expected in 2016. Article

> ReWalk Robotics stumbles 6 months after IPO. Story

Pharma News

@FiercePharma: Japan's Riken plans trial on transplanting stem cells of unrelated donors. FiercePharmaAsia article | Follow @FiercePharma

@EricPFierce: India's Micro Labs, whose Bangalore plant was banned by FDA, is recalling simvastatin made at Goa facility. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: We're back with #FierceMadness Round 3 today. Did you miss us? More at FiercePharmaMarketing | Follow @CarlyHFierce

> Gilead warns of fatal reaction to Sovaldi, Harvoni and heart drug. More

> AbbVie CEO pads $16M paycheck with $500K in jet travel. News

Animal Health News

> Integrated Animal Health forms 10-year research pact with NMSU on herd health. More

> 3D Systems preps for global launch of 'printed' knee implants for dogs. Article

> Researchers examine role of dog ownership on beneficial bacteria. Item

> VCA division Antech buys Abaxis vet-lab assets for $21M. News

> Wild birds to blame for avian flu outbreak? Not so fast, say scientists. Story

Biotech IT News

> Cloud Pharmaceuticals allies with U. of Florida to advance in silico pipeline. News

> FDA under pressure to establish staff social media policy. More

> Big Pharma nervously eying Apple and Google's healthcare pitches. Item

> India crowdsources whistleblowing with website, mobile app. Story

> AstraZeneca taps Assay Depot to create preclinical service hub. Report

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.